AUGMENT THERAPEUTICS

Augment Therapeutics is an early-stage pharmaceutical research and development company, and its mission is to "Leveraging Off-Patent Medicines" and strives to invent "Enhanced" versions of many widely used existing generic drugs that suffer from significant drawbacks or limitations by using our proprietary novel linker/prodrug technologies. In the process, we have invented the below mentioned "Enhanced" versions of widely used existing drugs such as naproxen, aspirin, and irinotecan. We strongly believe that these "Enhanced Medicines or E-Medicines", due to their competitively advantageous properties over their respective parent drugs, are ideal candidates for development through USFDA's efficient 505(b)(2) regulatory route, which is the least expensive and shortest route to drug development and approval without the need for conducting very expensive and time-consuming phase II and Phase III studies... However, we are planning to conduct a few relevant in vitro and in vivo preclinical..

Also known as: Augment Therapeutics Pvt Ltd, Augmenttherapeutics.com

Primary location: Foothill Ranch United States